Your browser doesn't support javascript.
loading
Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review.
de Filette, Jeroen M K; Pen, Joeri J; Decoster, Lore; Vissers, Thomas; Bravenboer, Bert; Van der Auwera, Bart J; Gorus, Frans K; Roep, Bart O; Aspeslagh, Sandrine; Neyns, Bart; Velkeniers, Brigitte; Kharagjitsingh, Aan V.
Afiliação
  • de Filette JMK; Department of Endocrinology, Universitair Ziekenhuis Brussel, Brussels, Belgium.
  • Pen JJ; Diabetes Clinic, Universitair Ziekenhuis Brussel, Brussels, Belgium.
  • Decoster L; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium.
  • Vissers T; Medical Library, Haaglanden Medical Center, Hague, The Netherlands.
  • Bravenboer B; Department of Endocrinology, Universitair Ziekenhuis Brussel, Brussels, Belgium.
  • Van der Auwera BJ; Diabetes Research Center, Vrije Universiteit Brussel, Brussels, Belgium.
  • Gorus FK; Diabetes Research Center, Vrije Universiteit Brussel, Brussels, Belgium.
  • Roep BO; Department of Immunohematology & Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands.
  • Aspeslagh S; Department of Diabetes Immunology, Diabetes & Metabolism Research Institute, City of Hope, Duarte, California, USA.
  • Neyns B; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium.
  • Velkeniers B; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium.
  • Kharagjitsingh AV; Department of Endocrinology, Universitair Ziekenhuis Brussel, Brussels, Belgium.
Eur J Endocrinol ; 181(3): 363-374, 2019 Sep.
Article em En | MEDLINE | ID: mdl-31330498

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Antineoplásicos Imunológicos Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Antineoplásicos Imunológicos Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article